BBBY Stock Forecast: Bed Bath & Beyond rises ahead of second quarter earnings call
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get Premium without limits for only $9.99 for the first month
Access all our articles, insights, and analysts.
UNLOCK OFFER- BBBY gained 1.25% during Wednesday’s trading session.
- Bed Bath & Beyond will report its earnings on Thursday before the markets open.
- Meme stocks gain for the second straight day as Netflix releases new short squeeze documentary.
Bed Bath & Beyond (BBBY) put together two consecutive positive trading days ahead of its second quarter earnings call on Thursday before the markets open. On Wednesday, shares of BBBY gained 1.25% and closed the trading session at a price of $6.46. Stocks finally snapped their losing streak as all three major averages rebounded off of the fresh bear market lows seen on Tuesday. The Dow Jones and the S&P 500 both ended their six-day slides and added 548 basis points and 1.97%, respectively. The Nasdaq led the way with a 2.05% gain despite an uncharacteristic tumble from Apple (AAPL) after rumours circulated about slowing demand for its iPhone 14.
BBBY stock price
On Thursday before the markets open, Bed Bath & Beyond will report its second quarter earnings. Analysts have a consensus earnings estimate of -$1.80 per share, and it certainly appears to be a bleak report given the events of the recent quarter. It should be noted that last quarter, Bed Bath & Beyond missed on earnings by $1.44, and yet the stock did not move much. This could be a case of all of the bad news already being baked into the current stock price.
Meme stocks also rallied as a sector on Wednesday as GameStop (GME) and AMC (AMC) rose again, while AMC’s APE preferred units traded flat. The sector could be receiving some extra chatter as Netflix (NFLX) released its documentary on the short squeeze saga entitled Eat the Rich: the GameStop Saga. It will be interesting to see how these stocks react to Bed Bath & Beyond’s earnings on Thursday morning.
BBBY 5-minute chart
- BBBY gained 1.25% during Wednesday’s trading session.
- Bed Bath & Beyond will report its earnings on Thursday before the markets open.
- Meme stocks gain for the second straight day as Netflix releases new short squeeze documentary.
Bed Bath & Beyond (BBBY) put together two consecutive positive trading days ahead of its second quarter earnings call on Thursday before the markets open. On Wednesday, shares of BBBY gained 1.25% and closed the trading session at a price of $6.46. Stocks finally snapped their losing streak as all three major averages rebounded off of the fresh bear market lows seen on Tuesday. The Dow Jones and the S&P 500 both ended their six-day slides and added 548 basis points and 1.97%, respectively. The Nasdaq led the way with a 2.05% gain despite an uncharacteristic tumble from Apple (AAPL) after rumours circulated about slowing demand for its iPhone 14.
BBBY stock price
On Thursday before the markets open, Bed Bath & Beyond will report its second quarter earnings. Analysts have a consensus earnings estimate of -$1.80 per share, and it certainly appears to be a bleak report given the events of the recent quarter. It should be noted that last quarter, Bed Bath & Beyond missed on earnings by $1.44, and yet the stock did not move much. This could be a case of all of the bad news already being baked into the current stock price.
Meme stocks also rallied as a sector on Wednesday as GameStop (GME) and AMC (AMC) rose again, while AMC’s APE preferred units traded flat. The sector could be receiving some extra chatter as Netflix (NFLX) released its documentary on the short squeeze saga entitled Eat the Rich: the GameStop Saga. It will be interesting to see how these stocks react to Bed Bath & Beyond’s earnings on Thursday morning.
BBBY 5-minute chart
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.